TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $233,436 | +31.7% | 15,521 | +3.6% | 0.09% | +22.9% |
Q4 2022 | $177,284 | +99.2% | 14,986 | 0.0% | 0.07% | +75.0% |
Q3 2022 | $89,000 | +39.1% | 14,986 | 0.0% | 0.04% | +48.1% |
Q2 2022 | $64,000 | -55.2% | 14,986 | 0.0% | 0.03% | -43.8% |
Q1 2022 | $143,000 | -30.9% | 14,986 | +141.2% | 0.05% | -26.2% |
Q3 2021 | $207,000 | -14.1% | 6,214 | 0.0% | 0.06% | -13.3% |
Q2 2021 | $241,000 | – | 6,214 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |